Toronto, Canada

Adam Paul Kafal

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Adam Paul Kafal: Innovator in Cyclic Peptides

Introduction

Adam Paul Kafal is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cyclic peptides, holding a total of seven patents. His work focuses on innovative solutions targeting specific integrins, which are crucial in various biological processes.

Latest Patents

Among his latest patents are "Cyclic peptides multimers targeting α4β7 integrin." This patent describes multimers comprising a plurality of compounds covalently linked together, with the compounds independently being of a specific formula. Another patent with a similar title further emphasizes his focus on cyclic peptides and their applications in targeting α4β7 integrin.

Career Highlights

Throughout his career, Adam has worked with esteemed organizations such as Zealand Pharma A/S and Université de Montréal. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of biochemistry and pharmaceuticals.

Collaborations

Adam has collaborated with several professionals in his field, including Manuel Perez Vazquez and Jennifer L Hickey. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Adam Paul Kafal is a distinguished inventor whose work in cyclic peptides has the potential to impact medical science significantly. His innovative patents and collaborations highlight his commitment to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…